Project leads
Collaborators

SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer

Tzyy-Choou Wu

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Tzyy-Choou Wu

Johns Hopkins University

Baltimore, United States

Related projects

Global Noncommunicable Diseases Intiatives

Cervical Cancer Screening and Preventative Therapy via Reproductive Health Networks (CCS&PT)

Global Noncommunicable Diseases Intiatives

Cervical Cancer Vacination Programme - Train the Trainers

Charles Wood

Cancer Research International Training and Intervention Consortium (CRITIC)

Non-Hodgkin lymphoma Kaposi sarcoma Cervix uteri

E. Blair Holladay

Partners for Cancer Diagnostic and Treatment in Africa

Thyroid Ovary Cervix uteri Breast All cancers but non-melanoma skin cancer

Rengaswamy Sankaranarayanan

Randomized trial of 2 versus 3 doses of HPV vaccine in India

Global Noncommunicable Diseases Intiatives

Improved Access to Health Services El Alto Bolivia - 2

Robert D. Burk

Persistent HPV Infection in Women at Risk for Cervix Cancer

Sora P Tanjasiri

CSUF and UCI-CFCCC Partnership for Cancer Health Disparities Research

Tzyy-Choou Wu

SPORE in Cervical Cancer - Master